Atenolol Tablet
FDA Label NDC 0093-0752

43 label sections · Submitted to the FDA by Teva Pharmaceuticals Usa, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Teva Pharmaceuticals Usa, Inc. for the product Atenolol (NDC 0093-0752). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, pharmacokinetics and metabolism, pharmacodynamics, atenolol geriatric pharmacology, hypertension, angina pectoris due to coronary atherosclerosis, acute myocardial infarction, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.